Franklyn Health was proud to take part in 4YFN – one of the world’s leading startup and innovation events, held in Barcelona. The appearance marked another major milestone in Franklyn Health’s continued growth and rising profile across the global MedTech and digital health ecosystem.
Laura Van Vaeck represented Franklyn Health as a speaker on the high-profile panel ‘Connected Health: Data, Devices and Decisions’, exploring the future of connected health, medical devices, and data-driven decision-making in modern healthcare. Speaking on the BStartup Banco Sabadell Stage, Laura shared Franklyn Health’s expertise in clinical strategy, regulatory, and market access for the medical device and diagnostics sector.
The session was an energising experience, and Franklyn Health extends its thanks to everyone who stopped by, shared ideas, and asked questions throughout the discussion.
Sharing the Stage at an Event of Global Calibre
Being selected to speak at 4YFN placed Franklyn Health among an exceptional community of innovators and industry leaders. The event’s wider programme featured a roster of high-calibre speakers from across the global health, investment, and technology sectors, including Lukas Saari (Tandem Health), Madeleine Thun (AstraZeneca), Jacky Abitbol (Cathay Innovation), Sara Secall (Inveready), and María González Manso (Tucuvi).
To be invited to speak at an event that attracts names of this stature is a clear reflection of Franklyn Health’s growing reputation and the increasing demand for its specialist expertise in MedTech clinical research, regulatory strategy, and market access.
Driving Conversations That Shape the Future of MedTech
Franklyn Health’s presence on the 4YFN stage reflected the company’s expanding influence across the MedTech and connected health space. By contributing to leading conversations on connected health, data, and medical devices, Franklyn Health continued to position itself at the forefront of healthcare innovation.
This added to a strong run of high-profile speaking engagements for the team, reinforcing Franklyn Health’s reputation as a trusted, highly skilled, and increasingly in-demand partner for emerging MedTech companies worldwide.
Purpose-Built for Emerging MedTech
Franklyn Health is purpose-built to partner with ambitious medical device and diagnostics manufacturers, helping them develop clinical strategy, solve complex regulatory challenges, and bring new technologies to market, faster.
Franklyn Health’s participation in 4YFN was the latest milestone in the company’s rapid growth — and its ongoing mission to lead the conversations shaping the future of MedTech, connected health, and clinical research.
